PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
Back to journals
Academic JournalOpen Access

Journal of Pain Research

2 Papers Indexed in Blossom

Data updated June 16, 2026

Research Footprint

Journal of Pain Research has 2 tracked papers indexed in Blossom (2019–2026) from 7 authors, most often covering Ketamine and Salvia Divinorum, across Chronic Pain, Headache Disorders (Cluster & Migraine) and Immunology & Inflammation.

Published Papers

Open Accessmeta

Oral Ketamine for Chronic Pain: Towards an Evidence-Based Dosing Regimen

This systematic review (s=27) of oral ketamine for chronic cancer and non-cancer pain found that mean pain scores fell from 7.72/10 to 3.2/10 over 30 to 90 days, though only 5 studies had sufficient dosing consistency for quantitative analysis, with 35 mg/70kg three times daily identified as an effective regimen with an acceptable safety profile.

Published
February 7, 2026
Journal
Journal of Pain Research
Authors
Winegarden, J., Brose, A., Storm, A., Mortensen, A., Carr, D.
Open Accessmeta

Salvia divinorum: from recreational hallucinogenic use to analgesic and anti-inflammatory action

This review (2019) examines the analgesic, anti-inflammatory, and psychoactive properties of the hallucinogenic plant Salvia Divinorum and its bioactive (analog) constituents.

Published
March 22, 2019
Journal
Journal of Pain Research
Authors
Coffeen, U., Pellicer, F.

Quick Facts

Papers Indexed
2
h-Index
77
Open Access
Yes
Publisher
Taylor & Francis
Country
New Zealand
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.